Streetbeat News

Products Services

CNTA

Centessa Pharmaceuticals announced that its preclinical data for ORX142, a drug targeting excessive daytime sleepiness, will be presented at Sleep Europe 2024. The data shows promising results in non-human primates.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 12:13 pm

LLY

Eli Lilly has introduced cheaper vials of its weight-loss drug Zepbound, priced up to 50% lower than other incretin medicines, to increase accessibility. The vials are available for self-pay patients with a valid prescription, expanding supply in response to high demand.

Portfolio Pulse from Vandana Singh

August 27, 2024 | 12:13 pm

SLNO

Soleno Therapeutics announced that the FDA has accepted its New Drug Application (NDA) for DCCR extended-release tablets, intended for the treatment of Prader-Willi Syndrome, and granted it priority review.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 12:12 pm

CMCSA

Comcast NBCUniversal SportsTech announced that the 10 companies in its fourth class have secured 15 pilots, partnerships, and commercial deals. The program connects early-stage companies with top sports brands, including NBC Sports and NASCAR.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 12:12 pm

LMT

TGLS

Two industrial stocks, Tecnoglass Inc (TGLS) and Lockheed Martin Corp (LMT), are considered overbought with RSI values above 70. Despite strong financial results and strategic deals, investors may want to reconsider holding these stocks due to potential short-term price corrections.

Portfolio Pulse from Avi Kapoor

August 27, 2024 | 12:11 pm

CMG

Chipotle is testing a new Honey Chicken menu item in Nashville and Sacramento, which combines spicy chipotle peppers with sweet honey. This follows high consumer taste test ratings.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 12:11 pm

ENSC

Ensysce Biosciences shares rose following a $14 million multi-year grant from the NIH to support the development of its abuse-deterrent opioid, PF614-MPAR.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 12:10 pm

MO

N/A

Altria and NJOY plan to appeal an ITC judge's initial ruling favoring JUUL in a patent dispute. NJOY is also pursuing alternative resolutions and FDA exemptions to continue marketing its ACE product.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 12:09 pm

ENSC

Ensysce Biosciences has been awarded a $14 million multi-year grant from the NIH to further develop its PF614-MPAR, an abuse-deterrent opioid with overdose protection. This funding will support the continued research and development of this innovative drug.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 12:09 pm

BIDU

GOOGL

TSLA

Tesla is expected to dominate the robotaxi market despite competitors like Waymo and Baidu having a first-mover advantage. Ark Invest analyst Tasha Kenney highlights Tesla's data scale advantage, while fund manager Gary Black emphasizes the importance of all companies in advancing autonomous driving. Tesla's upcoming robotaxi unveil event could provide more insights.

Portfolio Pulse from Shanthi Rexaline

August 27, 2024 | 12:08 pm